Core Insights - Global sleep health awareness is increasing, but there is a significant action gap where individuals recognize the importance of sleep yet fail to take steps to improve their sleep quality [2][3][10] Awareness and Action Gap - 53% of respondents consider sleep the most important factor for long-term health, surpassing diet and exercise, yet many do not take meaningful actions to enhance their sleep [2][7] - 84% of respondents acknowledge that consistent, quality sleep can extend a healthy lifespan, but 53% report getting quality sleep only four nights a week or less [3][7] Opportunities for Improvement - There is a clear opportunity to enhance education, screening, and diagnosis to help individuals identify sleep issues earlier and access care pathways [5] - The rise in wearable technology for sleep tracking has increased awareness, with usage among respondents growing from 16% in 2025 to 53% in 2026 [8] Gender Disparities - Nearly half of women surveyed (48%) struggle to fall asleep, an increase from 38% in 2025, with stress and anxiety being significant barriers [9] - Family responsibilities negatively impact sleep for 39% of women compared to 33% of men, highlighting a gender gap in sleep quality [9] Mental Health Connection - Insufficient sleep is linked to higher risks of anxiety and depression, with over a third of respondents reporting increased irritability (36%) and stress (33%) after poor sleep [9] Workplace Impact - More than half of respondents (58%) believe heavy workloads negatively affect their sleep, and 70% report taking a "snooze day" after a poor night's sleep [9] Relationship Dynamics - Sleeping together is associated with stronger intimacy, with 53% of respondents noting a positive impact on their sex life, although 80% experience some level of partner-related sleep disruption [9]

Core Insights - The 2026 Resmed Global Sleep Survey indicates a growing awareness of sleep health globally, yet a significant action gap persists between recognizing the importance of sleep and taking steps to improve sleep quality [2][3][4]. Awareness and Action Gap - Over half (53%) of respondents consider sleep the most important factor for long-term health, surpassing diet and exercise, but many do not take meaningful actions to enhance their sleep [2][7]. - Despite 84% of respondents acknowledging that quality sleep can extend a healthy lifespan, 53% report achieving a good night's sleep only four nights a week or less, illustrating the disconnect between awareness and action [3][4]. Opportunities for Improvement - The findings highlight a clear opportunity for enhanced education, screening, and diagnosis to help individuals identify sleep issues earlier and access appropriate care pathways [5]. - Increased use of wearable technology for sleep tracking has surged from 16% in 2025 to 53% in 2026, with 62% of wearable users indicating they would seek medical advice if their device flagged a potential risk [8]. Gender Disparities - Nearly half (48%) of women surveyed struggle to fall asleep, an increase from 38% in 2025, with stress and anxiety cited as significant barriers [9]. - Family responsibilities negatively impact sleep for 39% of women compared to 33% of men, further widening the gender gap in sleep quality [9]. Mental Health and Sleep - Insufficient sleep is linked to higher risks of anxiety and depression, with over a third of respondents reporting increased irritability (36%) and stress (33%) after poor sleep [9]. - A quarter (25%) of respondents globally reported feelings of depression following inadequate sleep [9]. Workplace Impact - More than half (58%) of respondents believe heavy workloads adversely affect their sleep, and 70% have taken a "snooze day" due to poor sleep [9]. - Flexible working arrangements are seen as beneficial by 59% of respondents in managing their sleep [9]. Relationship Dynamics - Sleeping together is associated with improved intimacy, with 53% of respondents noting a positive impact on their sex life, while 39% report their partner interrupts their sleep at least weekly [9].

Core Insights - Resmed is opening a new distribution center in Greenwood, Indiana, set to begin operations in 2027, aimed at expanding its U.S. presence and enhancing distribution capacity across North America [1][2] Group 1: Job Creation and Community Impact - The Greenwood center is expected to create over 100 full-time and contingent jobs in operations, logistics, and management [2] - Resmed is collaborating with local and state partners, including the State of Indiana and the City of Greenwood, to support job creation and advance the project [2][4] Group 2: Operational Efficiency - The new center will serve as a major logistics hub, improving two-day transit coverage across North America from 75% to 90% and reducing delivery times to Canada by one full day [3] - The central location of the Greenwood center will enhance connectivity between coastal operations and support improvements in efficiency, productivity, and delivery speed [3] Group 3: Company Commitment and Vision - Resmed's decision to establish the center in Greenwood reflects its commitment to investing in local communities and enhancing service delivery to patients and providers [4] - The company aims to redefine home healthcare through innovative technologies, empowering individuals to achieve better health outcomes [5]

Core Viewpoint - Resmed is set to release its financial and operational results for the second quarter of fiscal year 2026 on January 29, 2026, after market close, followed by a management webcast to discuss the results and other relevant information [1]. Company Overview - Resmed is dedicated to creating life-changing health technologies, focusing on innovative solutions that empower individuals in 140 countries to lead healthier lives [2]. - The company utilizes AI-powered digital health solutions, cloud-connected devices, and intelligent software to enhance home healthcare, making it more personalized and effective [2]. - Resmed envisions a future where everyone can achieve their full potential through improved sleep and breathing, with care provided in their own homes [2]. Earnings Webcast Details - The earnings webcast will take place on January 29, 2026, at 1:30 p.m. PST / 4:30 p.m. EST, with international times noted for London and Sydney [3]. - A replay of the webcast will be available on Resmed's investor relations website approximately two hours after the live event, with a phone replay accessible from January 29, 2026, until February 12, 2026 [2].

Core Viewpoint - Resmed will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, highlighting its commitment to innovative health technologies [1]. Company Overview - Resmed (NYSE: RMD, ASX: RMD) develops health technologies aimed at improving the quality of life for individuals in 140 countries [3]. - The company focuses on AI-powered digital health solutions, cloud-connected devices, and intelligent software to enhance home healthcare [3]. - Resmed envisions a future where individuals can achieve better sleep and breathing through personalized care delivered at home [3]. Event Details - The presentation will be made by Mick Farrell, chairman and CEO, and Dr. Carlos Nunez, chief medical officer [1]. - Access to the live audio-only webcast of the event will be available on Resmed's investor relations website, with a replay accessible for 30 days post-event [2].

Core Viewpoint - Resmed plans to release its financial and operational results for Q1 of fiscal year 2026 on October 30, 2025, after market close, followed by a management webcast to discuss the results and other relevant information [1]. Group 1: Earnings Release Details - The earnings release will occur on October 30, 2025, after the New York Stock Exchange closes [1]. - A webcast will be hosted by Resmed management to discuss the results and other forward-looking information [1]. - A replay of the earnings webcast will be available on Resmed's investor relations website approximately two hours after the live event [2]. Group 2: Company Overview - Resmed is dedicated to creating innovative health technologies aimed at improving the quality of life for individuals in 140 countries [2]. - The company focuses on AI-powered digital health solutions, cloud-connected devices, and intelligent software to enhance home healthcare [2]. - Resmed envisions a future where individuals can achieve better sleep and breathing through personalized care delivered at home [2].

Core Viewpoint - Resmed will present at the Bank of America Global Healthcare Conference 2025, highlighting its commitment to innovative health technologies and solutions [1]. Company Information - Resmed (NYSE: RMD, ASX: RMD) focuses on creating life-changing health technologies aimed at improving the quality of life for individuals [3]. - The company is dedicated to pioneering innovative technology that empowers millions across 140 countries to lead healthier lives [3]. - Resmed's offerings include AI-powered digital health solutions, cloud-connected devices, and intelligent software designed to enhance home healthcare [3]. - The company's vision is to enable every individual to reach their full potential through improved sleep and breathing, with care provided in their own homes [3]. Event Details - Mick Farrell, the chairman and CEO, along with Dr. Carlos Nunez, the chief medical officer, will present at the conference on September 23, 2025, at approximately 1:20 p.m. British Summer Time in London [1]. - Additional information about the event, including access to a live audio-only webcast, can be found on Resmed's investor relations website [2]. - A replay of the audio-only webcast will be available approximately 24 hours after the live event and will remain accessible for 30 days [2].

Core Insights - Resmed has elected Nicole Mowad-Nassar to its board of directors, effective August 15, 2025, while thanking Rich Sulpizio for his two decades of service as he retires from the board [1][5]. Group 1: Board Changes - Nicole Mowad-Nassar is currently the President of Specialty and U.S. Therapeutics Operations at AbbVie, managing a $6 billion commercial portfolio across 17 therapeutic areas and overseeing a workforce of 6,000 [2]. - Rich Sulpizio has served on Resmed's board since 2005, chairing the Compensation Committee and serving on the Audit Committee and Nominating and Governance Committee [5][6]. - Mowad-Nassar will serve as an independent director and has been appointed to the Compensation and Leadership Development Committee, standing for reelection at the 2025 Annual Meeting of Stockholders [4]. Group 2: Professional Background - Mowad-Nassar has over 30 years of experience in strategic, commercial, and operational roles within the pharmaceutical and healthcare sectors, with a focus on digital innovation [7]. - At AbbVie, she played a key role in the commercial integration of the $63 billion Allergan acquisition, ensuring continuity in product launches while minimizing operational disruption [3]. Group 3: Leadership Perspectives - Mick Farrell, Resmed's Chairman and CEO, highlighted Mowad-Nassar's extensive experience and commitment to patient access and digital engagement, indicating her potential to enhance the board's strategic direction [4]. - Farrell expressed gratitude for Sulpizio's contributions, noting his energy and people-first mindset during board discussions [6].

Company Overview - Resmed is set to release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025, after the NYSE closes [1] - The company is dedicated to creating innovative health technologies that enhance the quality of life for individuals in 140 countries [2] - Resmed's vision includes empowering people to achieve better sleep and breathing through personalized home healthcare solutions [2] Earnings Webcast Details - Following the earnings release, Resmed management will host a webcast to discuss the results and other forward-looking information [1] - The earnings webcast will be accessible via a specific link, with no outside phone lines used for access [1] - A replay of the webcast will be available on Resmed's investor relations website approximately two hours after the live event [2] Contact Information - For investor inquiries, Resmed provides a dedicated contact number and email [3] - Media inquiries can also be directed to a specific contact number and email [3] - Additional details regarding the webcast timing and international access are provided [3][4]

Core Insights - Resmed has been named the Official Sleep Partner of the Qatar Airways British & Irish Lions Tour to Australia, highlighting its commitment to promoting sleep health in sports [1][3][6] Company Overview - Resmed is a leading health technology company focused on sleep, breathing, and home care, aiming to empower individuals to live healthier lives through innovative technologies [1][13] - The company operates in 140 countries and emphasizes the importance of quality sleep as a critical component of overall health [13] Campaign Details - The 'Tackle Your Sleep' campaign will feature legendary rugby players and aims to raise awareness about sleep health issues affecting both players and fans [3][5] - The campaign will provide advice and tools to improve sleep quality, emphasizing its significance alongside exercise and diet [3][5] Health Implications - Poor sleep can negatively impact mental and physical health, relationships, and daily performance, particularly for athletes [4][5] - A study indicated that half of the rugby and cricket players surveyed were classified as poor sleepers, with many experiencing significant daytime fatigue [4][5] Tour Information - The British & Irish Lions Tour will take place over six weeks, featuring matches in six cities across Australia, with an estimated 40,000 fans participating [2][8] - The Lions will play a total of 10 matches, including three Test matches against the Wallabies [8]